UPDATE | June 28, 2026

Outsourcing formulation development & manufacturing: Connecting your project to the right service provider

  • MAIL

The CDMO market is projected to grow from $273 billion in 2026 to nearly $581 billion by 2034, driven by complex formulations and highly potent APIs that demand specialized partners. Samsung Biologics' Derrick Katayama highlights surging demand for high-concentration biologics enabling subcutaneous delivery, as the company's S-HiCon™ platform helps clients overcome solubility and stability challenges at concentrations exceeding 100 mg/mL.


Read the full report to explore how 30+ CDMOs are solving real-world formulation and manufacturing challenges.

The CDMO market is projected to grow from $273 billion in 2026 to nearly $581 billion by 2034, driven by complex formulations and highly potent APIs that demand specialized partners. Samsung Biologics' Derrick Katayama highlights surging demand for high-concentration biologics enabling subcutaneous delivery, as the company's S-HiCon™ platform helps clients overcome solubility and stability challenges at concentrations exceeding 100 mg/mL.


Read the full report to explore how 30+ CDMOs are solving real-world formulation and manufacturing challenges.

Share article

  • MAIL

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required